How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bio-Decolorant Market
- By Source Type: Microbial Enzymes, Plant Extracts, Algal Extracts, Animal-Derived Enzymes
- By Application: Textile Industry, Pulp and Paper Industry, Wastewater Treatment, Food Industry, Cosmetics Industry
- By Form: Liquid, Powder, Gel
- By Enzyme Type: Laccase, Peroxidase, Manganese Peroxidase, Lignin Peroxidase
- By End-User: Industrial Manufacturers, Environmental Agencies, Research Institutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Microbial Enzymes leads By Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Bio-Decolorant Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Source Type 4
Application 5
Form 3
Enzyme Type 4
End-User 3
Companies profiled
Novozymes A/S
Chr. Hansen Holding A/S
BASF SE
DSM (Royal DSM N.V.)
DuPont de Nemours Inc.
Evolva Holding SA
Amyris Inc.
Genencor (a division of DuPont)
AB Enzymes GmbH
Creative Enzymes
Advanced Enzyme Technologies Ltd.
Kerry Group plc
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Novozymes A/S
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Chr. Hansen Holding A/S
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →DSM (Royal DSM N.V.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →DuPont de Nemours Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Evolva Holding SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Amyris Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Genencor (a division of DuPont)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →AB Enzymes GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Creative Enzymes
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Advanced Enzyme Technologies Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Kerry Group plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Biocatalysts Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Lallemand Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Codexis
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →
Global · 2025–2033
$11,287M by 2033 · 10.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Microbial Enzymes63.5
- Plant Extracts13.3
- Algal Extracts8.6
- Animal-Derived Enzymes14.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,641M → $4,146M · 12.3%
Europe$1,144M → $2,489M · 10.2%
Asia Pacific$1,045M → $2,554M · 11.8%
Latin America$646.6M → $1,393M · 10.1%
Middle East and Africa$497.4M → $1,033M · 9.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.752026
10.762027
10.762028
10.772029
10.792030
10.802031
10.822032
10.822033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Novozymes A/S12.3
- Chr. Hansen Holding A/S21.7
- BASF SE10.8
- DSM (Royal DSM N.V.)12.3
- DuPont de Nemours Inc.10.3
- Evolva Holding SA4.7
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Type11.8%
Application24.6%
Form24.3%
Enzyme Type28.6%
End-User10.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.7
- Europe21.4
- Asia Pacific22.0
- Latin America12.0
- Middle East and Africa8.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Novozymes A/S | 95 | 79 | 87 | 98 | 88 | 98 | 91 |
| Chr. Hansen Holding A/S | 87 | 76 | 74 | 78 | 70 | 86 | 79 |
| BASF SE | 69 | 64 | 74 | 79 | 76 | 64 | 71 |
| DSM (Royal DSM N.V.) | 75 | 64 | 80 | 64 | 69 | 65 | 70 |
| DuPont de Nemours Inc. | 65 | 52 | 61 | 52 | 62 | 71 | 61 |
| Evolva Holding SA | 53 | 57 | 68 | 52 | 47 | 57 | 56 |
| Amyris Inc. | 59 | 44 | 55 | 40 | 54 | 45 | 50 |
| Genencor (a division of DuPont) | 41 | 57 | 41 | 46 | 60 | 51 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Novozymes A/S
- Chr. Hansen Holding A/S
- BASF SE
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Novozymes A/S | ✓ | ✓ | ◐ | ✓ | ✓ | ✓ |
| Chr. Hansen Holding A/S | ✓ | ◐ | ✓ | ◐ | ◐ | ✓ |
| BASF SE | − | − | ✓ | ✓ | ◐ | ◐ |
| DSM (Royal DSM N.V.) | ◐ | − | ✓ | − | ◐ | − |
| DuPont de Nemours Inc. | ◐ | − | − | − | ◐ | ◐ |
| Evolva Holding SA | − | ◐ | ◐ | ◐ | − | ◐ |
| Amyris Inc. | − | − | ◐ | − | ◐ | − |
| Genencor (a division of DuPont) | − | ◐ | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Novozymes A/S91
2Chr. Hansen Holding A/S79
3BASF SE71
4DSM (Royal DSM N.V.)70
5DuPont de Nemours Inc.61
6Evolva Holding SA56
7Amyris Inc.50
8Genencor (a division of DuPont)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Novozymes A/SChr. Hansen Holding A/S
Challenger2
Strong scale, closing on the leaders.
BASF SEDSM (Royal DSM N.V.)
Contender1
Focused players with pockets of strength.
DuPont de Nemours Inc.
Niche3
Specialists in a single segment or region.
Evolva Holding SAAmyris Inc.Genencor (a division of DuPont)
Go-to-market strategy
Land Source Type in North America, then scale across Bio-Decolorant Market — a $638M beachhead inside a $11.4B market.
Beachhead (SOM)$638Mobtainable near-term
Serviceable (SAM)$4.55Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Microbial Enzymes
Best fit — highest urgency & budget in Source Type.
Economic buyer79 fit
Plant Extracts
Strong fit — clear ROI and a fast path to value.
End user67 fit
Algal Extracts
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve18%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bio-Decolorant Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified25%
Evaluation13%
Closed-won7%
$12.5KCAC
$49KLTV
3.9:1LTV : CAC
< 3 moCAC payback
Investment thesis
Bio-Decolorant Market is a high-growth opportunity — $6.50B by 2033, compounding at 11.0%.
TAM · 2025$2.82Btoday
TAM · 2033$6.50Bforecast
CAGR11.0%2027–2033
Cumulative$40.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.50BTotal addressable market
SAM$2.28BServiceable available market
SOM$488MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.0% CAGR
Demand compounds through 2033, outpacing GDP across Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.50BLarge & growingTAM by 2033 at 11.0% CAGR
$2.28BServiceable nowreachable with today’s model
$488MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.07BBear7.2% CAGR
$6.50BBase11.0% CAGR
$8.33BBull14.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bio-Decolorant Market — a $4.80B market by 2033. Plan: grow share from 7.3% to 12.5%.
Market size · 2033$4.80Btotal addressable
Market CAGR10.7%2027–2033
Target share12.5%from 7.3% today
Revenue ambition$600Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 12.5% | On track |
| Revenue | $345M | $600M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 34.1% | 40.6% | On track |
| Customer retention | 88.3% | 94.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $81M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentAt risk
Sales deck · value proposition
Win the Bio-Decolorant Market conversation — a $5.71B market you can size, segment and defend in minutes.
Market size · 2033$5.71Btotal opportunity
Growth7.4%CAGR to 2033
Addressable buyers1,174+accounts in scope
Typical ROI5.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Type
Goal Grow share in Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.4×return on cost, year one
< 4 mopayback period
$74K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Novozymes A/SChr. Hansen Holding A/SBASF SEDSM (Royal DSM N.V.)DuPont de Nemours Inc.Evolva Holding SAAmyris Inc.Genencor (a division of DuPont)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bio-Decolorant Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bio-Decolorant Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Biodegradable Agricultural Film Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportBiodegradable Antirust Oil Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportBiodegradable Bag Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBiodegradable Cat Litter Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportBiodegradable Catheter Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportBiodegradable Composite Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportBio-Degradable Drinking Straws Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportBiodegradable Expandable Hemostatic Sponge Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBiodegradable Film Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportBiodegradable Food Cling Film Market
Market size, share, segmentation and regional forecast.
$809M market · 2025 base year
View reportBiodegradable Grass Seed Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportBiodegradable Heart Stent Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.